Online TRT: compare testosterone therapy clinics

Testosterone replacement therapy, usually shortened to TRT, is a prescription treatment that supplies testosterone from outside the body to men whose own production has fallen below the normal range. Delivered as an injection, gel, cream, patch or implanted pellet, it raises circulating testosterone back toward a normal range, and because the body detects the added hormone it also suppresses the signal driving your own production and your sperm count. TRT and enclomiphene are different treatments: TRT supplies the hormone directly, while enclomiphene blocks the estrogen feedback that holds your own production down, which is why enclomiphene is the route usually chosen by men who want to preserve fertility. The Endocrine Society's 2018 clinical practice guideline recommends diagnosing hypogonadism only in men who have both symptoms and unequivocally low morning testosterone confirmed on repeat testing, so one low reading is not a diagnosis (J Clin Endocrinol Metab 2018;103(5):1715-1744). Compounded testosterone and compounded enclomiphene are not FDA-approved products.

Real all-in online TRT costs more than the advertised headline once you add membership, medication, and labs. Hone men's Plus costs $135/mo plus medication; Basic at $25/mo excludes hormone therapy. Initial and confirmatory tests bring Plus TRT's first month to $225 to $260 before medication. The cheapest flat package is MangoRx at $99/mo covering visits, consultations and the medication, with labs billed on top at $75 or $100, so month one is $174 to $199 [Verified August 2026]. See our TRT cost page for the full per-clinic math.

Four steps: (1) blood work: confirm the required baseline and repeat tests and their costs in the provider’s review; (2) a telehealth consult with a licensed clinician; (3) diagnosis: the American Urological Association criterion is a total testosterone below 300 ng/dL on two separate early-morning draws, plus symptoms; (4) if you qualify, the prescription ships to your door on a subscription. Any clinic that will prescribe testosterone without lab work first is a red flag, not a shortcut.

Usually cheaper and always more comparable. Brick-and-mortar men's clinics typically run $150 to $250/mo and rarely publish prices. You find out the cost after the free consult sales pitch [Reported]. Online clinics ship to your door, include messaging or video follow-ups, and at least some of them publish real numbers you can compare before handing over a card. What you give up: in-person injections and a physical exam. If a local clinic won't quote a price before you book, treat the online prices on this page as your negotiating baseline.

TRT replaces testosterone from outside the body, which suppresses your own production and can crash sperm count. Enclomiphene works upstream: it stimulates your own testicular production via LH and FSH, which preserved sperm concentration in clinical trials. That makes it the option for men who want children. Caveats: it is not FDA-approved and is sold as a compounded drug, and results are more variable than injections. Price: $42/mo at Hone [Reported].

Insurance often covers the medication itself (generic testosterone cypionate with a documented low-T diagnosis) through a PCP or urologist, with labs billed to your plan. But none of the online clinics in this wing bill insurance: all are cash-pay, some accept HSA/FSA. So the real choice is insurance route (cheaper drug, slower process, prior-authorization friction) versus cash telehealth (priced by the required membership, medication and testing). If you have good coverage and patience, ask your doctor first.

The trial built to answer that question found no increase in major cardiovascular events, and most testosterone labels have not been updated to say so. TRAVERSE randomised 5,246 men aged 45 to 80 with cardiovascular disease or high risk of it and reported a first event of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in 7 percent on testosterone against 7.3 percent on placebo, hazard ratio 0.96 (95% CI 0.78 to 1.17). FDA reviewed those results and issued class-wide labeling changes dated 2/28/2025, recommending that the TRAVERSE results be added to all testosterone products. On 2026-08-26 we counted every testosterone label in the openFDA index: 19 of 120 mention TRAVERSE, and 66 of 120 still print the older sentence saying long-term cardiovascular trials have not been conducted. Read that sentence as an unrevised document rather than as an open question. The caveat TRAVERSE itself reported: atrial fibrillation, acute kidney injury, pulmonary embolism were each more frequent in the testosterone arm. This is not medical advice and the decision belongs with a licensed clinician.

Yes. Testosterone is a Schedule III controlled substance, and legitimate telehealth clinics prescribe it under DEA telemedicine rules after required lab work and a licensed-clinician evaluation. What varies wildly is disclosure and fulfillment, which is why we grade transparency on an A-F axis that sits apart from the 0-10 score: it rates what a clinic tells you before intake, not how good the care is. Red flags for any TRT site: no labs required, no named clinicians, no published prices, and reviews that only live on the clinic's own domain.